Literature DB >> 34964831

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022.

Boris Draznin, Vanita R Aroda, George Bakris, Gretchen Benson, Florence M Brown, RaShaye Freeman, Jennifer Green, Elbert Huang, Diana Isaacs, Scott Kahan, Jose Leon, Sarah K Lyons, Anne L Peters, Priya Prahalad, Jane E B Reusch, Deborah Young-Hyman.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34964831     DOI: 10.2337/dc22-S009

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  72 in total

1.  Optimizing the Use of Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes: Executive Summary.

Authors:  John Anderson; James R Gavin; Davida F Kruger; Eden Miller
Journal:  Clin Diabetes       Date:  2022

Review 2.  THE ABCDE'S OF PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE.

Authors:  Roger S Blumenthal; Abdulhamied Alfaddagh
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

3.  Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.

Authors:  Hiroshi Takahashi; Yuka Suganuma; Takayuki Ohno; Rimei Nishimura
Journal:  Diabetol Int       Date:  2022-03-16

4.  Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY).

Authors:  Ayca Diren; Deniz Kanca Demirci; Nurdan Gul; Burcin Karacanli; Aykut Baykut; Yildiz Tutuncu; Oguz Ozturk; Ilhan Satman; Hulya Yilmaz-Aydogan
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 5.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

6.  Individualized Glycemic Goals for Older Adults Are a Moving Target.

Authors:  Scott J Pilla; Zhinous Shahidzadeh Yazdi; Simeon I Taylor
Journal:  Diabetes Care       Date:  2022-05-01       Impact factor: 17.152

Review 7.  Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?

Authors:  Eun-Jung Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2022-06-29

8.  Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells in vitro.

Authors:  Kasja Pavlovic; Nina Krako Jakovljevic; Andjelka M Isakovic; Tijana Ivanovic; Ivanka Markovic; Nebojsa M Lalic
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

9.  Females with Diabetes Mellitus Increased the Incidence of Premenstrual Syndrome.

Authors:  Yao-Ming Huang; Wu-Chien Chien; Chun-Gu Cheng; Yin-Han Chang; Chi-Hsiang Chung; Chun-An Cheng
Journal:  Life (Basel)       Date:  2022-05-24

Review 10.  New Hypoglycemic Drugs: Combination Drugs and Targets Discovery.

Authors:  Xiayun Ni; Lei Zhang; Xiaojun Feng; Liqin Tang
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.